The discovery of a breast lump is one of the most anxiety-provoking occurrences in a woman's life. The initial purpose of a surgical consultation is to determine whether a true mass exists. The majority of breast masses are self-discovered or are identified by a primary care provider. Once a breast mass has been identified, the first determination to be made is whether it is benign or malignant by using breast imaging techniques or pathologic examination. Once a breast lesion has been shown to be benign on pathologic examination, the most improtant clinical consideration is the risk of subsequent breast cancer associated with that lesion. The diagnosis of a fibroadenoma can be made using excisional biopsy or the combined modalities of CBE, ultrasound, and FNA. A true intraductal papilloma develops in one of the major subareolar ducts and is the most common lesion causing a serous or serosanguinous discharge. A mass may be felt on examination in as many as one-third of cases. The treatment of choice is microdochectomy. Hamartomas can produce a classic mammographic image that is virtually diagnostic. Because the clinical and radiologic characteristics of fat necrosis resemble those of carcimoma in the majority of cases, a needle localization or excisional biopsy is required.
Biopsy ; Breast Neoplasms ; Breast* ; Diagnosis ; Fat Necrosis ; Fibroadenoma ; Hamartoma ; Needles ; Papilloma, Intraductal ; Primary Health Care ; Ultrasonography

No abstract available.
Breast Neoplasms* ; Breast* ; Drug Therapy*

No abstract available.
Nipples*

No abstract available.
Breast Neoplasms* ; Breast* ; Lymph Node Excision* ; Lymph Nodes*

No abstract available.
Breast Neoplasms* ; Breast* ; Drug Therapy*

No abstract available.
Stomach Neoplasms* ; Stomach*

PURPOSE: The study was to evaluate the various risk factors related to local recurrence and distant metastasis in early breast cancer treated by lumpectomy with axillary dissection MATERIALS AND METHODS: Forty nine patients with early breast cancer were treated by lumpectomy with axillary dissection between January, 1990 and December, 1996. We analysed the risk factors such as age, tumor size, axillary lymph node metastasis, stage, pathologic classification and radiotherapy for local recurrence and distant metastasis RESULTS: The peak incidence was in the fifth decade (15 cases, 31%) and the average age was 47. The most common tumor size was 0~2 cm in 27 of 49 cases (55%). The preoperative chemotherapy was performed in 25 of 49 cases. The axillary lymph node metastasis was absent in 41 of 49 cases (84%). The most common pathologic type was invasive ductal carcinoma (29 cases, 60%). The breast skin incision was performed with curvilinear incision in 40 cases (85%), radial incision in 7 cases (15%). The axillary skin incision was performed with seperated incision in 45 cases (96%), nonseperated incision in 2 cases (4%). The most common complication was wound seroma (6 cases, 12%). By the time of follow-up, crude local recurrence rate was 10% (5 out of 49 cases) and crude distant metastasis rate was 6% (3 out of 49 cases). CONCLUSION: The factors such as age, tumor size, positive axillary nodes and stage were not statistically significantly related to local recurrence. Postoperative radiation therapy and preoperative chemotherapy were the significant factor related to local recurrence (2.6% for 39 cases with radiation therapy vs. 40.0% for 10 cases without radiation therapy, p<0.05; 0% for 25 cases with preoperative chemotherapy vs. 20.8% for 24 cases without preoperative chemotherapy, p<0.05).
Breast Neoplasms* ; Breast* ; Carcinoma, Ductal ; Classification ; Drug Therapy ; Follow-Up Studies ; Humans ; Incidence ; Lymph Nodes ; Mastectomy, Segmental* ; Neoplasm Metastasis ; Radiotherapy ; Recurrence ; Risk Factors ; Seroma ; Skin ; Wounds and Injuries

BACKGROUND: Cystosarcoma phyllodes are relativly rare neoplasms of the breast and have an unpredictable clinical behavior. This study is to determine whether histological features correlate with clinical behavior, and which operation method affect recurrence. METHODS: This study reviewed the histological features and clinical outcomes in 12 patients with phyllode tumors of the breast diagnosed at Chungnam University Hospital from 1989 to 1998. RESULTS: The pathological results revealed benign forms were in 8 cases and malignant forms in 4 casese. As to the nature of the growth, the tumors in 10 cases grew rapidly 10 cases were rapid in nature, but two malignant tumors not. One of the 4 malignant tumors was high grade, the others were borderline. Eight (8) patients were had been treated conservatively (7 cases, wide tumor excision; 1 case, excisional biopsy), and 4 cases patients underwent radical operation (2 cases, modified radical mastectomy; other 2 cases, simple mastectomy). Only one patient with borderline malignancy, who underwent modified radical mastectomy, experienced recurrence. CONCLUSIONS: Tumor growth & histological features do not correlate with recurrence, and wide resection should to be primary treatement and axillary dissection is not worthwhile.
Breast* ; Chungcheongnam-do ; Humans ; Mastectomy, Modified Radical ; Phyllodes Tumor* ; Recurrence

No abstract available.
Breast Neoplasms* ; Breast*

PURPOSE: Nodal involvement has long been known to represent the single most reliable indicator of the prognosis in early-stage breast cancer. In common parlance, high-risk node-positive breast cancer has generally been used to describe patients who have involvement of ten or more axillary lymph nodes (10 LN). Patients with 10 LN clearly have a strikingly high risk of recurrence and death. Thus we tried to evaluate the clinical courses of breast cancer patients with more than 10 positive axillary lymph nodes. METHODS: Of 587 breast cancer patients operated on at Chungnam National University Hospital from Feb. 1992 to Nob. 1999, 31 cases (5.3%) showed involvement of more than 10 axillary lymph nodes. We evaluated the clinical courses of these patients and differences in survival related to clinical and pathologic vaiables. Survival was calculated using the Kaplan-Meier method. RESULTS: The mean age of the patients was 50 14 years. A mastectomy was performed in 28 cases (90.3%), and a breast conserving operation in 3 cases (9.7%). The mean tumor size was 4.8 2.5 cm. The mean number of removed axillary LN was 23.5 10.2 (10-52), and the mean number of positive axillary LN was 20.0 10.1 (10-51). At a median follow-up of 30.5 months, 23 cases (74.2%) of recurrence were noted. Among these 69.6% (16/23) showed distant metastases as a first recurrence. The 3-year and 5-year disease-free survivals were 28.6% and 22.9%, respectively. The 3-year and 5-year expected overall survivals were 53.7% and 41.8%, respectively. There were significantly more recurrences in patients who had given up adjuvant chemotherapy than patients who had completed 6 cycles of FEC or MMM. Also, significant survival benefits were noted in patients who were treated using combination chemotherapy with taxane plus cisplatin after recurrence. CONCLUSION: Breast cancer patients with 10 LN have a strikingly high risk of recurrence. Six (6) cycles of adjuvant chemotherapy with FEC or MMM was a controllable variable for lowering the risk of recurrence. Also, combination chemotherapy with taxane and cisplatin was a controllable variable for increasing survival after recurrence.
Breast Neoplasms* ; Breast* ; Chemotherapy, Adjuvant ; Chungcheongnam-do ; Cisplatin ; Disease-Free Survival ; Drug Therapy, Combination ; Follow-Up Studies ; Humans ; Lymph Nodes* ; Mastectomy ; Neoplasm Metastasis ; Prognosis ; Recurrence